BAXTER INTERNATIONAL INC (BAX)

US0718131099 - Common Stock

40.4  +0.93 (+2.36%)

After market: 40.8599 +0.46 (+1.14%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

BAXTER INTERNATIONAL INC

NYSE:BAX (4/22/2024, 7:04:00 PM)

After market: 40.8599 +0.46 (+1.14%)

40.4

+0.93 (+2.36%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap20.58B
Shares
PE14.96
Fwd PE13.8
Dividend Yield2.93%
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

BAX Daily chart

Company Profile

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company is headquartered in Deerfield, Illinois and currently employs 60,000 full-time employees. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.

Company Info

BAXTER INTERNATIONAL INC

Df2-1W, One Baxter Pkwy

Deerfield ILLINOIS 60015

P: 18479482000

CEO: Jose E. Almeida

Employees: 60000

Website: https://www.baxter.com/

BAX News

News Image12 days ago - Market News VideoMay 31st Options Now Available For Baxter International (BAX)
News Image12 days ago - Baxter International Inc.Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
News Image19 days ago - BloombergPfizer, Thermo Fisher Among 200 Companies Warned by FTC Over Deals

The US Federal Trade Commission warned hundreds of companies including Pfizer Inc., Baxter International Inc. and Thermo Fisher Scientific Inc. that it could challenge their acquisitions even after the deadline for the agency’s antitrust review had passed.

News Image22 days ago - Baxter International Inc.Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
News Image26 days ago - Market News VideoInteresting BAX Put And Call Options For May 10th
News Imagea month ago - Baxter International Inc.Baxter to Host Annual Meeting of Stockholders in Virtual Format

BAX Twits

Here you can normally see the latest stock twits on BAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example